Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Wall Street
Price Targets
BMRN Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for
BMRN
is 92.49 USD
with a low forecast of 60.6 USD and a high forecast of 126 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMRN's stock price target?
Price Target
92.49
USD
According to Wall Street analysts, the average 1-year price target for
BMRN
is 92.49 USD
with a low forecast of 60.6 USD and a high forecast of 126 USD.
What is Biomarin Pharmaceutical Inc's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Biomarin Pharmaceutical Inc's revenue is
15%.
The projected
CAGR
for the next 3 years is
13%.
What is Biomarin Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's operating income for the next 3 years is
13%.
What is Biomarin Pharmaceutical Inc's Net Income forecast?
Projected CAGR
58%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's net income for the next 3 years is
58%.
